Removal of parvovirus B19 from contaminated factor VIII during fractionation
- 1 September 1991
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 35 (1) , 28-31
- https://doi.org/10.1002/jmv.1890350107
Abstract
A solution of pooled cryo-precipitate for preparing factor VIII (F VIII) by the solvent/detergent method was contaminated experimentally with parvovirus B19-positive plasma to evaluate virus reduction achieved by the final steps of the F VIII production process. Virus reduction was at least 2 logs of the total amount of B19 virus added to the pooled cryo-precipitate. The major amount of B19 virus was detected in the solution used to regenerate the F VIII-selective anion exchange chromatography column. A few viral particles were detected in the final F VIII concentrate before filtration but these were aggregates and were removed by filtration, and in the solution used to regenerate the anion exchange resin. It is not known whether the residual viral DNA present in the final product represents infectious or inactivated particles.Keywords
This publication has 14 references indexed in Scilit:
- Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 1990
- SYMPTOMATIC PARVOVIRUS B19 INFECTION AND HEAT-TREATED FACTOR IX CONCENTRATEThe Lancet, 1989
- PERSISTENT B19 PARVOVIRUS INFECTION AS A CAUSE OF SEVERE CHRONIC ANAEMIA IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKAEMIAThe Lancet, 1988
- Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentratesJournal of Medical Virology, 1988
- Replication of the B19 Parvovirus in Human Bone Marrow Cell CulturesScience, 1986
- HUMAN PARVOVIRUS AND PURPURAThe Lancet, 1985
- Experimental Parvoviral Infection in HumansThe Journal of Infectious Diseases, 1985
- VIRAEMIA WITH HUMAN PARVOVIRUSThe Lancet, 1985
- TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 1983
- PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIAThe Lancet, 1981